Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Posaconazole is a promising new treatment for toenail fungus.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

CTP-543 is generally safe for treating alopecia areata.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Ruxolitinib can cause a delayed skin reaction on the nose.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

Gestrinone pellets may help reduce pelvic pain in endometriosis safely.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Long-term alcohol exposure alters brain receptor function differently in various brain regions.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Drug misuse can cause serious eye infections and other severe side effects.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Nail loss may be a side effect of the MS drug teriflunomide.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.